Little Relief for UnitedHealth
Investors at first cheered the managed care provider’s plans to cut costs on July 2, if it were not that the shares wound up closing lower amid increasing concerns approximately its margins
by dint of. David Bogoslaw
That sound you heard on Wall Street on July 2 was a tentative sigh of relief upon UnitedHealth Group’s (UNH) announcement that it was cutting its 2008 profit outlook by dint of. 16%—a move widely expected by investors—and slashing 4,000 jobs as part of a cost-cutting effort. The moves lifted shares of the two UnitedHealth and the broader managed health-care group. Only later in the day did the challenges the industry faces in the next year or two come back into focus, causing the public funds to come off their earlier highs.
The Minneapolis-based health-care provider said it now expects adjusted earnings for the full year to exist $2.95 to $3.05 a share, from a thin to a dense state from its prior forecast of $3.55 to $3.60 a share. The company also reduced its scheming for cash flow from operations to nearly $5 billion from a previous range of $5.7 billion to $6 billion.
Separately, the company said it will pay about $912 million to settle two cleave rank actions filed completely stock options backdating.
Chief Executive Stephen Helmsley cited smaller-than-expected gross margins from the company’s commercial risk business, which serves employees enrolled in their company health plans, during the second mercy. It also said efforts to raise premiums have lowered enrollment so farther this year, which has contributed to the humiliate earnings estimate.
A Sector on HoldTalk began to spread among investors two weeks ago that a down revision was coming at the epoch UnitedHealth declined to affirm its original earnings forecast later Coventry Health Care (CVH) slit its full-year income outlook by nearly 17%. At that time, other managed-care providers such as Aetna (AET) and Humana (HUM) did reaffirm their initial profit projections.
UnitedHealth shares, which had been falling since the last week in May, traded as much as 6.4% higher before sliding back to close 2% degrade, at $25.12, on July 2. Aetna also gave back earlier gains to end slightly lower, while WellPoint (WLP) and Coventry perfect higher, albeit off their intraday peaks.
Thomas Carroll, every analyst at Stifel Nicolaus (SF) in Baltimore, attributed the transient rebound in UnitedHealth’s handle to short-covering by investors who bet against the stock in anticipation of a reduced profits. forecast. "There’s a feeling that it’s not going to be in possession of any worse. Deep-value investors who be seized of been waiting on the sidelines to come by past this hurdle are starting to support this dunderhead. We’re seeing it across the whole sector," says Carroll, who has a "hold" rating on the undivided sector.
Painful But Manageable PaymentsElimination of the concerns around the company’s litigation exposure helped the stock price rebound temporarily. UnitedHealth said it will salary $895 very great number to settle a federal securities rank action filed in December 2006 against the company and positive progression and former officers and directors immersing backdating of stock options. The proposed settlement reached with chief plaintiff, the California Public Employees’ Retirement System, and prosecutor class representative Alaska Plumbing & Pipefitting Industry Pension Trust in the rank action will fully resolve all claims against the company, all course officers and directors named in the lawsuit, and stated constructer officers and directors named in the lawsuit, the company said in a news release.
Original text: http://www.businessweek.com/investor/content/jul2008/pi2008072_417239.htm?campaign_id=rss_null
